ClearanceBrief
Recall Z-0106-2026 ยท CEM Electrode, Ion Specific, Potassium

Inpeco S.A.

FlexLab (FLX) System. Potassium Test System. in vitro diagnostic

DateOct 9, 2025 (initiated Sep 3, 2025)
StatusOpen, Classified
ReasonThe FlexLab System Sample Integrity Module (SIM) includes function that determines the hemolysis, icterus, and lipemia (HIL) in blood samples. This function has not been evaluated for safety and effectiveness by the FDA, so its use may cause an increase in erroneous results or a delay in patient results.
Root causeNo Marketing Application
ActionConsignees received an Urgent Medical Device Recall notification via email dated 9/3/25. The notification instructs consignees to not rely on HIL functionality for clinical decision making or to flag potentially erroneous samples. HIL functionality must be discontinued and cannot be disabled by users. Inspeco must send an Inspeco Servicer to consignee locations to disable HIL functionality. Inspeco will contact consingnees to schedule this service. Consignees are to forward the provided notification to those whom it might concern. Consignees with questions can contact Regulatory Affairs via em
Quantity8 units
DistributionUS distribution to CA & NY.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K121012FLEXLAB 3.6, ACCELERATOR A3600
Inpeco S.P.A., Aug 31, 2012